Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Staphylococcus aureus Protein vraC (vraC) CSB-YP765802SUL
CSB-EP765802SUL
CSB-BP765802SUL
CSB-MP765802SUL
CSB-EP765802SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 50S ribosomal protein L25 (rplY) CSB-YP765803SUL
CSB-EP765803SUL
CSB-BP765803SUL
CSB-MP765803SUL
CSB-EP765803SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 2 (ispD2) CSB-YP765804SUL
CSB-EP765804SUL
CSB-BP765804SUL
CSB-MP765804SUL
CSB-EP765804SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Probable siderophore biosynthesis protein SbnA (sbnA) CSB-YP765805SUL
CSB-EP765805SUL
CSB-BP765805SUL
CSB-MP765805SUL
CSB-EP765805SUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Putative acetyltransferase SAV2555 (SAV2555) CSB-YP765806SKX
CSB-EP765806SKX
CSB-BP765806SKX
CSB-MP765806SKX
CSB-EP765806SKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Signal transduction protein TRAP (traP) CSB-YP765807SKX
CSB-EP765807SKX
CSB-BP765807SKX
CSB-MP765807SKX
CSB-EP765807SKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Transcriptional regulatory protein srrA (srrA) CSB-YP765808SKX
CSB-EP765808SKX
CSB-BP765808SKX
CSB-MP765808SKX
CSB-EP765808SKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Teichoic acids export ATP-binding protein TagH (tagH) CSB-YP765809SKX
CSB-EP765809SKX
CSB-BP765809SKX
CSB-MP765809SKX
CSB-EP765809SKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Putative ABC transporter ATP-binding protein SA2476 (SA2476), partial CSB-YP765810SKY
CSB-EP765810SKY
CSB-BP765810SKY
CSB-MP765810SKY
CSB-EP765810SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Protein translocase subunit SecA 2 (secA2), partial CSB-YP765811SKY
CSB-EP765811SKY
CSB-BP765811SKY
CSB-MP765811SKY
CSB-EP765811SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Staphylococcal secretory antigen ssaA1 (ssaA1) CSB-YP765812SKY
CSB-EP765812SKY
CSB-BP765812SKY
CSB-MP765812SKY
CSB-EP765812SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Ferrous iron transport protein B (feoB), partial CSB-YP765813SKY
CSB-EP765813SKY
CSB-BP765813SKY
CSB-MP765813SKY
CSB-EP765813SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator sarU (sarU) CSB-YP765814SKY
CSB-EP765814SKY
CSB-BP765814SKY
CSB-MP765814SKY
CSB-EP765814SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Uncharacterized oxidoreductase SA2266 (SA2266) CSB-YP765815SKY
CSB-EP765815SKY
CSB-BP765815SKY
CSB-MP765815SKY
CSB-EP765815SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Uncharacterized lipoprotein SA2158 (SA2158) CSB-YP765816SKY
CSB-EP765816SKY
CSB-BP765816SKY
CSB-MP765816SKY
CSB-EP765816SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Putative 2-hydroxyacid dehydrogenase SA2098 (SA2098) CSB-YP765817SKY
CSB-EP765817SKY
CSB-BP765817SKY
CSB-MP765817SKY
CSB-EP765817SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator sarV (sarV) CSB-YP765818SKY
CSB-EP765818SKY
CSB-BP765818SKY
CSB-MP765818SKY
CSB-EP765818SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 50S ribosomal protein L5 (rplE) CSB-YP765819SKY
CSB-EP765819SKY
CSB-BP765819SKY
CSB-MP765819SKY
CSB-EP765819SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus 50S ribosomal protein L13 (rplM) CSB-YP765820SKY
CSB-EP765820SKY
CSB-BP765820SKY
CSB-MP765820SKY
CSB-EP765820SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Low molecular weight protein-tyrosine-phosphatase ptpB (ptpB) CSB-YP765821SKY
CSB-EP765821SKY
CSB-BP765821SKY
CSB-MP765821SKY
CSB-EP765821SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>